Importantly, both local abnormalities of Aβ and Tau pathology can be detected by multi-photon excitation at a very early stage, indicating that the fluorescence approach has a greater advantage for identifying beneficial molecular clues linking early pathological change in AD model animals. The gene discussed is MAPT; the disease is Alzheimer disease.